Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2011
03/24/2011CA2774145A1 Hcv protease inhibitors
03/24/2011CA2773985A1 Protein kinase conjugates and inhibitors
03/24/2011CA2772689A1 Glycine compound
03/23/2011EP2298763A1 Method for producing 1-biphenylmethylimidazole compound
03/23/2011EP2298761A1 HIV inhibiting pyrimidines derivatives
03/23/2011EP2298748A2 Triazole compounds that modulate HSP90 activity
03/23/2011EP2298746A1 4-amino- quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
03/23/2011EP2298743A1 5-membered heterocycle-based P38 kinase inhibitors
03/23/2011EP2298738A1 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
03/23/2011EP2298734A2 Cyclobutyl amine derivatives
03/23/2011EP2298729A1 Method of producing optically active amino acid derivative
03/23/2011EP2298305A1 4-(N-Phenylamino)-quinazolines/quinolines as inhibitors of tyrosine kinases
03/23/2011EP2297138A1 Processes for the preparation of crystalline forms of sunitinib malate
03/23/2011EP2297118A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives
03/23/2011EP2297103A1 Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors
03/23/2011EP2297100A1 Tetrahydrocyclopentaýb¨indole androgen receptor modulators
03/23/2011EP2297098A1 Pyrrolidine derivatives as nk2 receptor antagonists
03/23/2011EP2297096A2 Aryl ketone as mri
03/23/2011EP2229358B1 Indoles and their therapeutic use
03/23/2011EP2081893B1 Substituted indoles
03/23/2011EP1888565B1 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
03/23/2011EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta
03/23/2011CN1942436B Lysine based compounds
03/23/2011CN101987848A New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing them
03/23/2011CN101987844A Method for synthesizing 4-(4-chlorobenzyl)-2-(hexahydro-1-methyl-1H-diazepoxide-4-radical)-1-(2H)-phthalizine hydrochloride
03/22/2011US7910731 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
03/22/2011US7910590 Cyclic amine bace-1 inhibitors having a heterocyclic substituent
03/22/2011US7910588 5-HT7 receptor antagonists
03/22/2011US7910585 Pyrimidine derivatives
03/22/2011US7910576 Pyrrole derivatives as P2Y12 antagonists
03/22/2011CA2632771C Substituted imidazoles and their use as pesticides
03/22/2011CA2513102C Substituted pyrazoles, compositions containing such compounds and methods of use
03/22/2011CA2488001C 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
03/22/2011CA2480880C Inhibitors of akt activity
03/22/2011CA2445333C Quinoline derivatives and quinazoline derivatives having azolyl group
03/17/2011WO2011031658A1 Herbicidal pyrimidone derivatives
03/17/2011WO2011031111A2 Alkoxy indole-3-acetic acid derivative acting as ppar α/γ/δ agonists, preparation method thereof, and pharmaceutical composition containing same as active ingredient
03/17/2011WO2011031100A2 Aripiprazole-bentonite-aea hybrid, pharmaceutical composition containing the same and method for preparing the same
03/17/2011WO2011031073A2 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof
03/17/2011WO2011030139A1 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators
03/17/2011WO2011030068A1 Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease
03/17/2011WO2011029920A1 Heterocylcic derivatives as inhibitors of glutaminyl cyclase
03/17/2011WO2011029807A1 Ortho substituted pyrimidine compounds as jak inhibitors
03/17/2011WO2011029633A1 Heterocyclic mglu5 antagonists
03/17/2011WO2011029537A1 Sustituted ( heteroarylmethyl ) thiohydantoins as anticancer drugs
03/17/2011WO2011029506A1 3-[1-(3-haloalkyl)-triazolyl]-phenyl-sulfide derivatives for use as acaricides and insecticides
03/17/2011WO2011029265A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
03/17/2011WO2011011105A3 Traceable retinoid acid for imaging, disease prevention and therapy
03/17/2011WO2010144646A3 Anti-viral compounds to treat hcv infection
03/17/2011US20110065919 5-Substituted Indol-3-Carboxylic Acid Derivatives Exhibiting Antiviral Activity a Method for the Production and Use Thereof
03/17/2011US20110065918 New phenylalanine derivatives
03/17/2011US20110065896 Polyether polyol dendron conjugates with effector molecules for biological targeting
03/17/2011US20110065768 Non-steroidal androgens compounds
03/17/2011US20110065767 Substituted CC-1065 Analogs and Their Conjugates
03/17/2011US20110065765 Angiotensin ii receptor antagonists
03/17/2011US20110065734 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
03/17/2011US20110065725 Triazole amide derivatives for use in therapy
03/17/2011US20110065724 Compounds that modulate intracellular calcium
03/17/2011US20110065722 A crystalline form of posaconazole
03/17/2011US20110065716 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
03/17/2011US20110065713 Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors
03/17/2011US20110065706 Therapeutic Agents 812
03/17/2011US20110065703 Novel agents of calcium ion channel modulators
03/17/2011US20110065702 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
03/17/2011US20110065691 Therapeutic piperazines
03/17/2011US20110065689 Therapeutic piperazines
03/17/2011US20110065685 Novel indoles are cannabinoid receptor ligands
03/17/2011US20110065684 Phthalazine derivatives as parp inhibitors
03/17/2011US20110065683 Trisubstituted pyrazoles as acetylcholine receptor modulators
03/17/2011US20110065682 Heterocyclic compounds as factor ixa inhibitors
03/17/2011US20110065681 Amide compounds, compositions and uses thereof
03/17/2011US20110064892 Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base
03/17/2011US20110064698 Hepatitis c virus inhibitors
03/17/2011US20110064697 Hepatitis c virus inhibitors
03/17/2011US20110064696 Hepatitis c virus inhibitors
03/17/2011US20110064695 Hepatitis c virus inhibitors
03/17/2011US20110063485 Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods
03/17/2011US20110062386 Compounds for organic light emitting diode emissive layers
03/17/2011CA2774099A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
03/17/2011CA2773591A1 Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs
03/17/2011CA2772697A1 Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease
03/17/2011CA2772488A1 Heterocyclic derivatives as inhibitors of glutaminyl cyclase
03/17/2011CA2771675A1 Ortho substituted pyrimidine compounds as jak inhibitors
03/17/2011CA2771588A1 Herbicidal pyrimidone derivatives
03/16/2011EP2295442A2 Inhibitors of interleukin-1beta converting enzyme
03/16/2011EP2295432A1 Process for the preparation of aminobenzimidazole derivatives
03/16/2011EP2295429A1 3-((hetero)aryl)-indazoles as Liver X receptor (LXR) and Th-1 inhibitors for the treatment of cardiovascular diseases
03/16/2011EP2295428A2 Linear pyridazine and pyrrolic compounds, methods of preparation and applications
03/16/2011EP2295416A2 Triazole compounds that modulate HSP90 activity
03/16/2011EP2295415A1 Quinazoline derivatives
03/16/2011EP2295414A1 Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
03/16/2011EP2295413A1 Indazole compounds useful as protein kinase inhibitors
03/16/2011EP2295412A1 Indazole compounds useful as protein kinase inhibitors
03/16/2011EP2295411A1 Pyrazoles as 11-beta-hsd-1
03/16/2011EP2295408A1 Matrix metalloproteinase inhibitors
03/16/2011EP2295401A2 Deuterated hepatitis C protease inhibitors
03/16/2011EP2294066A1 Benzoimidazoles as prolyl hydroxylase inhibitors
03/16/2011EP2294053A2 Glucokinase activators
03/16/2011EP2294051A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
03/16/2011EP2125789B1 Pyrimidinyl pyrazoles as insecticides and parasiticide active agents